OverviewChartNewsTraderScreen

CV Sciences, Inc./  US1266541028  /

Nasdaq Other OTC
5/24/2024  6:57:44 PM Chg. +0.0015 Volume Bid- Ask- High Low
0.0525USD +2.94% 219,125
Turnover: 11,616.8250		 -Bid Size: - -Ask Size: - 0.0557 0.0525
GlobeNewswire 3/28/2022 CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 31, 2022
GlobeNewswire 3/11/2022 UPDATE -- CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products
GlobeNewswire 3/8/2022 CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products
GlobeNewswire 1/24/2022 Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
GlobeNewswire 1/18/2022 Cannabis Industry Investor Conference: Company Executives Present January 19th & 20th
GlobeNewswire 1/11/2022 CV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief Topicals
GlobeNewswire 1/5/2022 CV Sciences, Inc. Announces New Distribution Agreement with GNC
GlobeNewswire 11/30/2021 CV Sciences, Inc. Appoints Haskell & White LLP as Auditor
GlobeNewswire 11/15/2021 CV Sciences, Inc. Announces Convertible Note Financing
GlobeNewswire 11/15/2021 CV Sciences, Inc. Reports Third Quarter 2021 Financial Results
GlobeNewswire 11/8/2021 CV Sciences, Inc. to Announce Third Quarter 2021 Results on November 15, 2021
GlobeNewswire 10/7/2021 CV Sciences, Inc. Applauds the California Legislature for Passage of AB 45
GlobeNewswire 8/12/2021 CV Sciences, Inc. Reports Second Quarter 2021 Financial Results
GlobeNewswire 8/5/2021 CV Sciences, Inc. to Announce Second Quarter 2021 Results on August 12, 2021
GlobeNewswire 7/27/2021 CV Sciences, Inc. Receives NutraIngredients-USA 2021 Product of the Year: Immune Support Award
GlobeNewswire 7/26/2021 ATEC Appoints Beth Altman to Board of Directors
GlobeNewswire 7/20/2021 CV Sciences, Inc. and University of California, San Diego Publish Study of Cannabidiol Efficacy in T...
GlobeNewswire 5/13/2021 CV Sciences, Inc. Reports First Quarter 2021 Financial Results
GlobeNewswire 5/11/2021 CV Sciences, Inc. Announces Launch of PlusCBD™ Calm and Sleep Gummies
GlobeNewswire 5/6/2021 CV Sciences, Inc. to Announce First Quarter 2021 Results on May 13, 2021
GlobeNewswire 4/13/2021 CV Sciences and Alkemist Labs Form Partnership to Support the National Institute of Standards and Te...
GlobeNewswire 3/31/2021 Roth Capital Partners Set to Host Upcoming Golden Cannabis Day Event on April 7, 2021
GlobeNewswire 3/18/2021 CV Sciences, Inc. Reports Fiscal Year-End 2020 Financial Results
GlobeNewswire 3/10/2021 CV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter 2020 Results on March 18, 2021
GlobeNewswire 1/5/2021 CV Sciences, Inc. Announces Launch of ProCBD™ Product Line